Tokyo - Delayed Quote JPY

Rohto Pharmaceutical Co.,Ltd. (4527.T)

Compare
2,710.50
+30.00
+(1.12%)
At close: January 17 at 3:45:01 PM GMT+9

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Yamada Kunio Chairman of the Board & CEO 212M -- 1956
Mr. Masashi Sugimoto President, COO & Director -- -- 1961
Mr. Saito Masaya EVP, CFO & Director -- -- 1963
Mr. Shinichi Kunisaki EVP, CTO & Director -- -- 1955
Mr. Hideto Kamimura Senior Executive Officer and General Manager of Marketing Division -- -- --
Mr. Yasunori Kawasaki CHRO & Director -- -- 1960
Hidetoshi Segi MD, Chief Strategy Officer & Director -- -- 1962

Rohto Pharmaceutical Co.,Ltd.

1-8-1, Tatsumi-nishi
Ikuno-ku
Osaka, 544-8666
Japan
81 6 6758 1231 https://www.rohto.co.jp
Full Time Employees: 
7,259

Description

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Corporate Governance

Rohto Pharmaceutical Co.,Ltd.’s ISS Governance QualityScore as of November 1, 2024 is 7. The pillar scores are Audit: 4; Board: 6; Shareholder Rights: 10; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 12, 2025 at 6:00 AM UTC

Rohto Pharmaceutical Co.,Ltd. Earnings Date

March 28, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers

4928.T Noevir Holdings Co., Ltd.
4,605.00
-0.22%
 
4967.T Kobayashi Pharmaceutical Co., Ltd.
5,763.00
+1.71%
 
4927.T Pola Orbis Holdings Inc.
1,392.50
+1.05%
 
8283.T Paltac Corporation
4,195.00
-0.40%
 
4919.T Milbon Co., Ltd.
3,175.00
+1.28%
 
0837.HK CARPENTER TAN
5.830
+0.34%
 
4922.T KOSÉ Corporation
6,737.00
+2.29%
 
8113.T Unicharm Corporation
1,217.50
+0.12%
 
ESSITY-B.ST Essity AB (publ)
300.30
+1.87%
 
COTY Coty Inc.
7.14
-0.83%